Inventor · disambiguated record
Hildegund C. J. Ertl
Also filed as: ERTL HILDEGUND C · ERTL HILDEGUND C J
19 granted patents·9 pending applications·358 citations·filing 1995–2025
94Inventor score
Top patents by PatentIndex Score
28 records- 0196US9402888B2Methods and compositions for treating cancerWISTAR INST·Filed 2014·Granted Aug 2, 2016·29 cites·9 claims
- 0292US6019978AReplication-defective adenovirus human type 5 recombinant as a vaccine carrierWISTAR INST·Filed 1996·Granted Feb 1, 2000·125 cites·6 claims
- 0390US11207402B2Constructs for enhancing immune responsesWISTAR INST·Filed 2019·Granted Dec 28, 2021·3 cites·9 claims
- 0489US9724406B2Constructs for enhancing immune responsesWISTAR INST·Filed 2015·Granted Aug 8, 2017·8 cites·13 claims
- 0589US8962816B2Constructs for enhancing immune responsesERTL HILDEGUND C J·Filed 2011·Granted Feb 24, 2015·26 cites·18 claims
- 0688US9624510B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2014·Granted Apr 18, 2017·6 cites·13 claims
- 0787US5698202AReplication-defective adenovirus human type 5 recombinant as a rabies vaccine carrierWISTAR INST·Filed 1995·Granted Dec 16, 1997·92 cites·11 claims
- 0887US2025354172A1Adenoviral Vectors Comprising Partial Deletions of E3THE WISTAR INST·Filed 2025·Application pending·0 cites
- 0985US12391959B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2023·Granted Aug 19, 2025·0 cites·6 claims
- 1085US11382886B2Methods and compositions for treating cancerWISTAR INST·Filed 2017·Granted Jul 12, 2022·2 cites·18 claims
- 1185US10328146B2Contructs for enhancing immune responsesWISTAR INST·Filed 2017·Granted Jun 25, 2019·4 cites·22 claims
- 1278US12390525B2Constructs for enhancing immune responsesWISTAR INST·Filed 2021·Granted Aug 19, 2025·0 cites·23 claims
- 1378US10953108B2Compositions and methods of replication deficient adenoviral vectors for vaccine applicationsWISTAR INST·Filed 2017·Granted Mar 23, 2021·1 cites·30 claims
- 1477US9744224B2Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigensWISTAR INST·Filed 2016·Granted Aug 29, 2017·1 cites·12 claims
- 1573US11702675B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 1673US10822619B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2019·Granted Nov 3, 2020·0 cites·13 claims
- 1771US6287571B1Replication-defective adenovirus human type 5 recombinant as a vaccine carrierWISTAR INST·Filed 1999·Granted Sep 11, 2001·23 cites·4 claims
- 1870US6210663B1Methods of augmenting mucosal immunity through systemic priming and mucosal boostingWISTAR INST·Filed 1999·Granted Apr 3, 2001·38 cites·13 claims
- 1965US10407696B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2017·Granted Sep 10, 2019·0 cites·12 claims
- 2059US2009246220A1Constructs for enhancing immune responsesERTL HILDEGUND C J·Filed 2007·Application pending·0 cites
- 2157US2024181041A1Adenovirus SARS-CoV-2 VaccineTHE WISTAR INST·Filed 2022·Application pending·0 cites
- 2254US2002164353A1Replication-defective adenovirus human type 5 recombinant as a vaccine carrierUNIV PENNSYLVANIA·Filed 2001·Application pending·0 cites
- 2351US2022211835A1Replication Deficient Adenoviral Vectors for HIV Vaccine ApplicationsTHE WISTAR INST·Filed 2019·Application pending·0 cites
- 2450US2006140908A1Methods for inducing an immune response via oral administration of an adenovirusERTL HILDEGUND C J·Filed 2004·Application pending·0 cites
- 2548US12485102B2Methods and compositions for treating cancerWISTAR INST·Filed 2018·Granted Dec 2, 2025·0 cites·14 claims
- 2643US2001000176A1Method of vaccinating infants against infectionsFiled 2000·Application pending·0 cites
- 2740US2014377295A1Influenza vaccines containing modified adenovirus vectorsERTL HILDEGUND C·Filed 2012·Application pending·0 cites
- 2836US2013209512A1Universal influenza a vaccinesERTL HILDEGUND C J·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hildegund C. J. Ertl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →